News

January 17, 2019January 17, 2019

Rare Tracheal Infection with Achromobacter in Bronchiectasis Patient Reported in Case Study

News

A rare infection of the trachea with the bacteria Achromobacter xylosoxidans deteriorated the respiratory function of an idiopathic bronchiectasis patient, a case study reports. The U.K. case report “Achromobacter xylosoxidans in ... Read more

January 10, 2019January 10, 2019

Statins, Mucolytics May Lower Risk of Exacerbations, Death Among BCO Patients, Study Finds

News

Statins and mucolytics may lower the risk of acute exacerbations and death among patients with bronchiectasis and chronic obstructive pulmonary disease (COPD), a Taiwanese study found. The study, “Mucolytic ... Read more

January 2, 2019January 3, 2019

Apulmiq’s Benefits Confirmed in Third-party Evaluation

News

A third-party evaluation (TPE) confirmed the efficacy of the bronchiectasis treatment candidate Apulmiq found in Phase 3 trials, Aradigm, the developer of the therapy, recently announced. Apulmiq, previously known as Linhaliq ... Read more

December 21, 2018December 21, 2018

Rising Healthcare Costs Strain EU Budgets Even as New Therapies Flourish

News

Cash-strapped governments across the 28-member European Union are struggling to control runaway healthcare expenditures — at exactly the same time as the promise of new but expensive therapies to ... Read more

December 20, 2018December 20, 2018

Mycobacterium abscessus Gave Rise to Autoimmune Disorder in Bronchiectasis Patient, Report Says

News

A first case of an autoimmune disorder characterized by inflammation of blood vessels in a bronchiectasis patient infected with Mycobacterium abscessus highlights the therapeutic challenges in managing nontuberculous mycobacteria ... Read more

December 13, 2018December 13, 2018

Zambon’s Inhalable Antibiotic for Non-CF Bronchiectasis Gets Fast Track, QIDP Status from FDA

News

The U.S. Food and Drug Administration (FDA) granted Qualified Infectious Diseases Product (QIDP) and Fast Track designations to Zambon’s inhalable colistimethate sodium product to help prevent non-cystic fibrosis bronchiectasis ... Read more

December 6, 2018December 6, 2018

‘Vascular Pruning’ Affects Lung Function in Smokers With Bronchiectasis

News

A recent study comparing computed tomography (CT) scan data found that smokers with bronchiectasis have a greater loss of blood vessels in the lungs, a process known as vascular ... Read more

November 29, 2018November 29, 2018

Pus in Sputum Associated with Disease-prone Bacteria in Bronchiectasis

News

The presence of pus (purulence) in sputum samples from bronchiectasis patients is associated with an imbalance in microbial communities and a higher prevalence of potential disease-prone bacteria, a new ... Read more

November 15, 2018November 15, 2018

Certain Autoantibodies Linked to P. aeruginosa Infection in Bronchiectasis Patients, Study Suggests

News

Production of autoantibodies against a particular protein called bactericidal/permeability-increased protein (BPI) is strongly associated with chronic Pseudomonas aeruginosa infection in patients with bronchiectasis, a study has found. BPI is an anti-microbial ... Read more

November 8, 2018November 8, 2018

New Probe Allows Safe, Easy Visualization of Infectious Bacteria in Lungs, Study Shows

News

A newly developed fluorescent probe allows the detection of infectious bacteria in human airways and lung’s air sacs within minutes, a study shows. This innovative diagnostic strategy was found ... Read more

Pin It on Pinterest